
Opioid-Sparing Ketorolac Protocol for Pain Control After Meniscus Surgery

Opioid-Sparing Ketorolac Protocol for Pain Control After Meniscus Surgery
An Opioid-Sparing Pain Protocol of Intravenous and Oral Ketorolac Reduces Opioid Consumption and Pain Levels After Arthroscopic Meniscus Surgery: A Prospective, Randomized Controlled Trial.
Arthroscopy . 2025 Jun;41(6):1989-2001.e1.Synopsis
Forty-eight patients with meniscal pathology undergoing arthroscopic meniscus surgery were randomized to receive oxycodone-acetaminophen alone (n = 25) or a ketorolac protocol—30 mg IV intraoperatively plus 10 mg orally every 6 hours for 3 days, with rescue oxycodone-acetaminophen (n = 23). The primary outcomes were VAS pain and opioid consumption (converted to MMEs) during postoperative days (POD...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Learn about our AI Driven
High Impact Search Feature

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.